The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
Open accessAbstract
The antitumorigenic activity of antioxidants has been presumed to arise from their ability to squelch DNA damage and genomic instability mediated by reactive oxygen species (ROS). Here, we report that antioxidants inhibited three tumorigenic models in vivo. Inhibition of a MYC-dependent human B lymphoma model was unassociated with genomic instability but was linked to diminished hypoxia-inducible factor (HIF)-1 levels in a prolyl hydroxylase 2 and von Hippel-Lindau protein-dependent manner. Ectopic expression of an oxygen-independent, stabilized HIF-1 mutant rescued lymphoma xenografts from inhibition by two antioxidants: N-acetylcysteine and vitamin C. These findings challenge the paradigm that antioxidants diminish tumorigenesis primarily through decreasing DNA damage and mutations and provide significant support for a key antitumorigenic effect of diminishing HIF levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, our NAC treated scramble shRNA expressing cells did form tumors, which is not consistent with the aforementioned study.”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Gao et al., 2007
In the citing paper
“Previously it was reported that NAC administration completely inhibits tumor formation in xenograft models (Gao et al., 2007).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Gao et al., 2007
In the citing paper
“ROS signals are sufficient to trigger the stabilization of HIFα (21, 31), and a recent study indicates that antioxidant therapy significantly inhibits tumor progression in vivo by inhibiting HIF activation (18).”
From Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis (2008) · cites this paper as [18]
In the citing paper
“there is growing evidence that HIF1α-dependent tumour growth may be inhibited by ascorbate78,79.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [79]
In the citing paper
“In a mouse model of myc-driven tumorigenesis, tumor growth is inhibited by treatment with antioxidants 70.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [70]
In the citing paper
“However, the effect of antioxidant treatment was a result of the inhibition of HIF accumulation: expression of a stable HIF mutant alone could provide resistance to antioxidant treatment.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [70]
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationHypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,137
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Weßendorf, S., Barth, T. F. E., Bernd, H., Cogliatti, S., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,002
Zhang, H., Gao, P., Fukuda, R., Kumar, G., Krishnamachary, B., Zeller, K. I., Dang, C. V., & Semenza, G. L. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.001 · Cited by 885
Self-citationc-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876
HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity
Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.006 · Cited by 781
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 523
Mitochondrial autophagy: Life and breath of the cell
Semenza, G. L. (2008) · Autophagy · doi:10.4161/auto.5956 · Cited by 75
Self-citationRole of FOXO Transcription Factors in Cancer Metabolism and Angiogenesis
Farhan, M., Silva, M., Xing, X., Huang, Y., & Zheng, W. (2020) · Cells · doi:10.3390/cells9071586 · Cited by 79
Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer
Reang, J., Sharma, P. C., Thakur, V. K., & Majeed, J. (2021) · Biomolecules · doi:10.3390/biom11081130 · Cited by 73
Evens, A. M., Sehn, L. H., Farinha, P., Nelson, B. P., Raji, A. A., Lu, Y., Brakman, A., Parimi, V., Winter, J. N., Schumacker, P. T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.1893 · Cited by 71
Perera, R. M., & Bardeesy, N. M. (2011) · Nature · doi:10.1038/475043a · Cited by 72
Suppression of Mitochondrial Complex I Influences Cell Metastatic Properties
He, X., Zhou, A., Lu, H., Chen, Y., Huang, G., Yue, X., Zhao, P., & Wu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061677 · Cited by 78
Emanuele, S., D’Anneo, A., Calvaruso, G., Cernigliaro, C., Giuliano, M., & Lauricella, M. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.7b00311 · Cited by 69
Kuiper, C., Dachs, G. U., Munn, D., Currie, M. J., Robinson, B. A., Pearson, J. F., & Vissers, M. C. M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00010 · Cited by 78
The Role of Antioxidants in Cancer, Friends or Foes?
Poljšak, B., & Milisav, I. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190123112647 · Cited by 69
Metabolic heterogeneity in cancer: An overview and therapeutic implications
Yu, T., Gao, W., & Liu, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188421 · Cited by 70
Fuloria, S., Subramaniyan, V., Sundram, K., Kumari, U., Sathasivam, K. V., Meenakshi, D. U., Wu, Y. S., Sekar, M., Chitranshi, N., Malviya, R., et al. (2021) · Antioxidants · doi:10.3390/antiox10010128 · Cited by 77
Chintala, S., Tóth, K., Cao, S., Durrani, F. A., Vaughan, M. M., Jensen, R. L., & Rustum, Y. M. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1238-8 · Cited by 70
Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition
Curran, C. S., & Keely, P. J. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.11.016 · Cited by 71
Myc induced replicative stress response: How to cope with it and exploit it
Rohban, S., & Campaner, S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.04.008 · Cited by 68
Campbell, E. J., Vissers, M. C. M., Wohlrab, C., Hicks, K. O., Strother, R. M., Bozonet, S. M., Robinson, B. A., & Dachs, G. U. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.08.027 · Cited by 67
TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis
Huang, Q., Wu, D., Zhao, J., Yan, Z., Chen, L., Guo, S., Wang, D., Yuan, C. G., Wang, Y., Liu, X., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021110324 · Cited by 68
A Role for Virally Induced Reactive Oxygen Species in Kaposi's Sarcoma Herpesvirus Tumorigenesis
Ma, Q., Cavallin, L. E., Leung, H. J., Chiozzini, C., Goldschmidt‐Clermont, P. J., & Mesri, E. A. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4584 · Cited by 70
PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells
Kim, B., Jung, J. W., Jung, J., Han, Y., Suh, D. H., Kim, H. S., Dhanasekaran, D. N., & Song, Y. S. (2017) · Oncotarget · doi:10.18632/oncotarget.19140 · Cited by 68
New Challenges to Study Heterogeneity in Cancer Redox Metabolism
Benfeitas, R., Uhlén, M., Nielsen, J., & Mardinoğlu, A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00065 · Cited by 67
Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
Pollard, P. J., Yang, M. H., Su, H., Soga, T., & Kranc, K. R. (2014) · Hypoxia · doi:10.2147/hp.s47968 · Cited by 66
Metabolic changes in cancer cells upon suppression of MYC
Ansó, E., Mullen, A. R., Felsher, D. W., Matés, J. M., DeBerardinis, R. J., & Chandel, N. S. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-7 · Cited by 64
Self-citationGu, R., Zhang, F., Chen, G., Han, C., Liu, J., Ren, Z., Zhu, Y., Waddington, J. L., Zheng, L. T., & Zhen, X. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.10.018 · Cited by 62
Jin, F., Yang, R., Yao, W., Wang, D., Zhu, Y., Wang, X., Lu, Y., Wang, Y., Zen, K., & Li, L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.025 · Cited by 61
Iovine, B., Oliviero, G., Garofalo, M., Orefice, M., Nocella, F., Borbone, N., Piccialli, V., Centore, R., Mazzone, M., Piccialli, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096755 · Cited by 61
Yustein, J. T., Liu, Y.-C., Gao, P., Jie, C., Le, A., Vuica‐Ross, M., Chng, W. J., Eberhart, C. G., Bergsagel, P. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901230107 · Cited by 58
Self-citationCholine and betaine consumption lowers cancer risk: a meta-analysis of epidemiologic studies
Sun, S., Li, X., Ren, A., Du, M., Du, H., Shu, Y., Zhu, L., & Wang, W. T. (2016) · Scientific Reports · doi:10.1038/srep35547 · Cited by 60
Campbell, E. J., Vissers, M. C. M., Bozonet, S., Dyer, A., Robinson, B. A., & Dachs, G. U. (2015) · Cancer Medicine · doi:10.1002/cam4.349 · Cited by 59
The Hypoxia-inducible Factor Renders Cancer Cells More Sensitive to Vitamin C-induced Toxicity
Tian, W., Wang, Y., Xu, Y., Guo, X., Wang, B., Sun, L., Liu, L., Cui, F., Zhuang, Q., Bao, X., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.538157 · Cited by 59
Antioxidants for prostate cancer chemoprevention: Challenges and opportunities
Thapa, D., & Ghosh, R. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.027 · Cited by 58
Function of reactive oxygen species in myeloid-derived suppressor cells
Huang, J., Zhao, Y., Zhao, K., Yin, K., & Wang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1226443 · Cited by 60
Mimeault, M., & Batra, S. K. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00115 · Cited by 59
The enemy of my enemy is my friend
Harris, I. S., & Brugge, J. S. (2015) · Nature · doi:10.1038/nature15644 · Cited by 58
Talib, W. H., Jum'Ah, D., Attallah, Z. S., Jallad, M. S., Kury, L. T. A., Hadi, R. W., & Mahmod, A. I. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1281879 · Cited by 64
Zheng, J., Lou, J. R., Zhang, X.-X., Benbrook, D. M., Hanigan, M. H., Lind, S. E., & Ding, W. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.07.003 · Cited by 57
Rodrigues, M. S., Reddy, M. M., & Sattler, M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2071 · Cited by 58
Carr, A. C., Pullar, J. M., Moran, S., & Vissers, M. C. M. (2012) · Journal of Nutritional Science · doi:10.1017/jns.2012.15 · Cited by 57
Wang, D., Xu, J., Liu, B., He, X., Zhou, L., Hu, X., Qiao, F., Zhang, A., Xu, X., Zhang, H., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.162 · Cited by 57
Self-citationGuo, L., Li, L., Wang, W., Pan, Z., Zhou, Q., & Wu, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.004 · Cited by 56
Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival
Foo, B. J.-A., Eu, J. Q., Hirpara, J. L., & Pervaiz, S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1341604 · Cited by 56
Hellfritsch, J., Kirsch, J., Schneider, M., Fluege, T., Wortmann, M., Frijhoff, J., Dagnell, M., Fey, T., Esposito, I., Kölle, P., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5889 · Cited by 57
Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness
Comito, G., Giannoni, E., Gennaro, P. D., Segura, C. P., Gerlini, G., & Chiarugi, P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.025 · Cited by 56
Bazine, I., Cheraiet, Z., Bensegueni, R., Bensouıcı, C., & Boukhari, A. (2020) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.3933 · Cited by 54
Overexpression of the c-myc Oncogene Inhibits Nonsense-mediated RNA Decay in B Lymphocytes
Wang, D., Wengrod, J., & Gardner, L. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266361 · Cited by 53
Hou, J., Qian, M., Zhao, H., Li, Y., Liao, Y., Han, G., Xu, Z., Wang, F., Song, Y., & Liu, Y. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.03.028 · Cited by 53
Pro- and antitumor effects of mitochondrial reactive oxygen species
Payen, V. L., Zampieri, L. X., Porporato, P. E., & Sonveaux, P. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09789-2 · Cited by 56
Park, Y.-K., Ahn, D., Oh, M., Tae-Kyoung, L., Yang, E. G., Son, M., & Park, H. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045278 · Cited by 52
Martin, L., & Gardner, L. B. (2014) · Oncogene · doi:10.1038/onc.2014.352 · Cited by 53
Seo, K., Seo, S., Ki, S. H., & Shin, S. M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.014 · Cited by 52
Sharifi, N., Hurt, E. M., Thomas, S. B., & Farrar, W. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0591 · Cited by 52
Current perspectives of mitochondria-targeted antioxidants in cancer prevention and treatment
Zinovkin, R. A., Lyamzaev, K. G., & Chernyak, B. V. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1048177 · Cited by 56
Fan, C.-S., Chen, W.-S., Chen, L.-L., Chen, C.-C., Hsu, Y.-T., Chua, K. V., Wang, H., & Huang, T. (2017) · Oncotarget · doi:10.18632/oncotarget.23578 · Cited by 51
Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer
El‐Sahli, S., & Wang, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239125 · Cited by 52
Barliya, T., Mandel, M., Livnat, T., Weinberger, D., & Lavie, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022849 · Cited by 50
Dong, A., Shen, J., Zeng, M., & Campochiaro, P. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012859108 · Cited by 54
Francesco, E. M. D., Ózsvári, B., Sotgia, F., & Lisanti, M. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00615 · Cited by 49
Vitamin C: From nutrition to oxygen sensing and epigenetics
Kietzmann, T. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102753 · Cited by 57
Yang, C., Matro, J. C., Huntoon, K. M., Ye, D. Y., Huynh, T., Fliedner, S. M. J., Breza, J., Jr., Zhuang, Z., & Pacák, K. (2012) · The FASEB Journal · doi:10.1096/fj.12-210146 · Cited by 52
Redox Molecular Machines Involved in Tumor Progression
Parri, M., & Chiarugi, P. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5040 · Cited by 47
Angiogenesis modulation by exogenous antioxidants
Radomska-Leśniewska, D. M., Bałan, B. J., & Skopiński, P. (2017) · Central European Journal of Immunology · doi:10.5114/ceji.2017.72804 · Cited by 46
Zhang, X., He, C., Yan, R., Chen, Y., Zhao, P., Li, M., Fan, T., Yang, T., Lu, Y., Luo, J., et al. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.122540 · Cited by 46
Noninvasive molecular imaging of c-Myc activation in living mice
Fan-Minogue, H., Cao, Z., Paulmurugan, R., Chan, C. T., Massoud, T. F., Felsher, D. W., & Gambhir, S. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007443107 · Cited by 46
Self-citationPharmacokinetic modeling of ascorbate diffusion through normal and tumor tissue
Kuiper, C., Vissers, M. C. M., & Hicks, K. O. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.023 · Cited by 45
Das, L., & Vinayak, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099583 · Cited by 45
Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma
Almeida, F. V., Douglass, S. M., Fane, M. E., & Weeraratna, A. T. (2018) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12736 · Cited by 47
Kwan, S.-Y., Cheng, X., Tsang, Y. T. M., Choi, J.-S., Kwan, S., Izaguirre, D. I., Kwan, H. S., Gershenson, D. M., & Wong, K. (2016) · Oncotarget · doi:10.18632/oncotarget.10921 · Cited by 43
Patel, N. N., Gonsalves, C. S., Yang, M., Malik, P., & Kalra, V. K. (2008) · Blood · doi:10.1182/blood-2008-07-169821 · Cited by 43
Mitochondria and Hypoxia‐induced Gene Expression Mediated by Hypoxia‐inducible Factors
Chavez, A., Miranda, L. F., Pichiule, P., & Chavez, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.021 · Cited by 43
Medjkane, S., Perichon, M., Marsolier, J., Dairou, J., & Weitzman, J. B. (2013) · Oncogene · doi:10.1038/onc.2013.134 · Cited by 46
Kozak, J., Jonak, K. E., & Maciejewski, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110037 · Cited by 42
Oncogenes strike a balance between cellular growth and homeostasis
Qiu, B., & Simon, M. C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.005 · Cited by 44
Reactive oxygen species and synthetic antioxidants as angiogenesis modulators: Clinical implications
Radomska-Leśniewska, D. M., Hevelke, A., Skopiński, P., Bałan, B. J., Jóźwiak, J., Rokicki, D., Skopińska-Różewska, E., & Białoszewska, A. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.10.002 · Cited by 42
KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis
Cavallin, L. E., Ma, Q., Naipauer, J., Gupta, S., Kurian, M., Locatelli, P., Romanelli, P., Nadji, M., Goldschmidt‐Clermont, P. J., & Mesri, E. A. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007175 · Cited by 41
Xiao, Y., Qin, T., Sun, L., Qian, W., Li, J., Duan, W., Lei, J., Wang, Z., Ma, J., Li, X., et al. (2020) · Cell Transplantation · doi:10.1177/0963689720929987 · Cited by 42
Metabolic Rewiring in Response to Biguanides Is Mediated by mROS/HIF-1a in Malignant Lymphocytes
Khan, H., Anshu, A., Prasad, A. K., Roy, S., Jeffery, J. J., Kittipongdaja, W., Yang, D. T., & Schieke, S. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.007 · Cited by 42
Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development
Grzywa, T. M., Justyniarska, M., Nowis, D., & Gołąb, J. (2021) · Cancers · doi:10.3390/cancers13040870 · Cited by 41
Lee, J. M., Lee, W. H., Kay, H. Y., Kim, E., Moon, A., & Kim, S. G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26075 · Cited by 40
A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis
Link, J. M., Ota, S., Zhou, Z.-Q., Daniel, C. J., Sears, R. C., & Hurlin, P. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206406109 · Cited by 38
Zong, S., Tang, Y., Li, W., Han, S., Shi, Q., Ruan, X., & Hou, F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00705 · Cited by 39
Chae, H. S., Park, H.-J., Hwang, H. R., Kwon, A., Lim, W.-H., Yi, W. J., Han, D.-H., Kim, Y. H., & Baek, J. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0071-1 · Cited by 42
Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer
Musolino, C., Allegra, A., Pioggia, G., & Gangemi, S. (2016) · Oncology Reports · doi:10.3892/or.2016.5291 · Cited by 41
N-acetylamino acid utilization by kidney aminoacylase-1
Lindner, H. A., Täfler-Naumann, M., & Röhm, K. (2008) · Biochimie · doi:10.1016/j.biochi.2007.12.006 · Cited by 38
Lv, C., Fu, S., Dong, Q., Yu, Z., Zhang, G., Kong, C., Fu, C., & Zeng, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1032-3 · Cited by 38
Zhou, T., Wu, J., Khan, A., Hu, T., Wang, Y., Salama, E., Su, S., Han, H., Jin, W., & Li, X. (2024) · npj Science of Food · doi:10.1038/s41538-024-00307-5 · Cited by 39
Ambient Oxygen Promotes Tumorigenesis
Sung, H. J., Ma, W., Starost, M. F., Lago, C. U., Lim, P. K., Sack, M. N., Kang, J., Wang, P.-Y., & Hwang, P. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019785 · Cited by 39
Zuo, D., Zhou, Z., Wang, H., Zhang, T., Zang, J., Yin, F., Sun, W. Y., Chen, J., Duan, L., Xu, J., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12957 · Cited by 37
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 37
Sceneay, J., Liu, M. C. P., Chen, A., Wong, C. S. F., Bowtell, D. D. L., & Möller, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066388 · Cited by 36
Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma
Vícha, A., Taïeb, D., & Pacák, K. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0398 · Cited by 35
Taming Tumor Glycolysis and Potential Implications for Immunotherapy
Ganapathy‐Kanniappan, S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00036 · Cited by 35
Bertout, J. A., Patel, S. A., Fryer, B. H., Durham, A. C., Covello, K. L., Olive, K. P., Goldschmidt, M. H., & Simon, M. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4223 · Cited by 36
Lee, W. H., Kim, Y., Choi, J. H., Brooks, S. C., Lee, M., & Kim, S. G. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0420 · Cited by 35
RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation
Engel, C., Brügmann, G., Lambing, S., Mühlenbeck, L. H., Marx, S., Hagen, C., Horváth, D., Goldeck, M., Ludwig, J., Herzner, A., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0129-t · Cited by 32
Unexpected antitumorigenic effect of fenbendazole when combined with supplementary vitamins.
Gao, P., Dang, C. V., & Watson, J. (2008) · Europe PMC (PubMed Central) · Cited by 34
Self-citationAscorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo
Mikirova, N. A., Casciari, J. J., & Riordan, N. H. (2010) · Vascular Cell · doi:10.1186/2040-2384-2-2 · Cited by 34
Regulation of the 2-oxoglutarate-dependent dioxygenases and implications for cancer
Vissers, M. C. M., Kuiper, C., & Dachs, G. U. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140118 · Cited by 32
Wang, Y., Li, C., Ali, I., Li, L., & Wang, G. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.09.011 · Cited by 32
Targeting myeloid-derived suppressor cells for cancer therapy
Tang, H., Li, H., & Sun, Z. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0806 · Cited by 32
Kao, Y., Kuo, Y.-M., Lee, Y.-R., Yang, S., Chen, W., & Lee, H. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.02.002 · Cited by 32
Li, S.-H., Ryu, J., Park, S.-E., Cho, Y.-S., Park, J., Lee, W.-J., & Chun, Y. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.06.004 · Cited by 32
Modulation of Cytokines in Cancer Patients by Intravenous Ascorbate Therapy
Mikirova, N. A., Riordan, N. H., & Casciari, J. J. (2016) · Medical Science Monitor · doi:10.12659/msm.895368 · Cited by 33
Metadata
- Authors
- Gao, P., Zhang, H., Dinavahi, R., Li, F., Xiang, Y., Raman, V., Bhujwalla, Z. M., Felsher, D. W., Cheng, L., Pevsner, J., Lee, L. A., Semenza, G. L., & Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Stanford Medicine (US)
- Corresponding author
- Dang, Chi V.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 12
- Issue
- 3
- Pages
- 230-238
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC2084208
- OpenAlex
- W2143182501
- Cited by
- 523
- References
- 41
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 15 · 2023: 28 · 2022: 25 · 2021: 36 · 2020: 21 · 2019: 23 · 2018: 23 · 2017: 38 · 2016: 32 · 2015: 26 · 2014: 46 · 2013: 22 · 2012: 30
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA057341, CA91596, CA 51497, P50CA103175, R37CA051497, R01CA091596, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- antioxidants, HIF-1, anti-tumorigenic effects, prolyl hydroxylase 2, von Hippel-Lindau protein, N-acetylcysteine, vitamin C, reactive oxygen species, genomic instability, DNA damage, lymphoma xenografts
- MeSH terms
- Acetylcysteine, Animals, Antineoplastic Agents, Antioxidants, Ascorbic Acid, Cell Line, Humans, Mice, Transgenic, Mutation, Genomic Instability, Mice, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review